40 Result(s)

Article

Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT

The optimal conditioning for patients with higher risk MDS receiving potentially curative allogeneic haematopoietic stem cell transplant(allo-HCT) remains to be defined. This is particularly the case for patie...

V. Potter, L. Gras, L. Koster, N. Kroger, K. Sockel… in Bone Marrow Transplantation (2024)

Article

Adverse environmental conditions are a risk factor for ocular GvHD after allogeneic hematopoietic stem cell transplantation

P. Steven, C. Faust, U. Holtick, C. Scheid, V. Tahmaz… in Bone Marrow Transplantation (2020)

Article

Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial

The Dutch-Belgian Cooperative Trial Group for Hematology Oncology Group-65/German-speaking Myeloma Multicenter Group-HD4 (HOVON-65/GMMG-HD4) phase III trial compared bortezomib (BTZ) before and after high-dose...

H Goldschmidt, H M Lokhorst, E K Mai, B van der Holt, I W Blau, S Zweegman… in Leukemia (2018)

Article

Impact of choice, timing, sequence and combination of broad-spectrum antibiotics on the outcome of allogeneic haematopoietic stem cell transplantation

Recent data link the incidence of intestinal GvHD (iGvHD) after allogeneic haematopoietic stem cell transplantation (aSCT) to exposure with piperacillin–tazobactam or imipenem–cilastatin. To assess relevance o...

F Farowski, V Bücker, J J Vehreschild, L Biehl… in Bone Marrow Transplantation (2018)

Article

Besonderheiten beim elektiven Hüftgelenkersatz des älteren Menschen

Aufgrund des demografischen Wandels wird eine zunehmend größere Anzahl von Patienten im fortgeschrittenen Lebensalter mit einer Hüfttotalendoprothese versorgt. Um eine sichere Versorgung des älteren Patienten ...

T. Claßen, C. Scheid, S. Landgraeber, Prof. Dr. M. Jäger in Der Orthopäde (2017)

Article

Nekrotisierende Fasziitis – eine klinische Diagnose

Die nekrotisierende Fasziitis ist ein lebensbedrohliches Krankheitsbild, welches bei verzögerter Diagnostik und inadäquater Therapie zu Multiorganversagen und Tod führt. Wir berichten im Folgenden von einem 68...

C. Scheid, M. Dudda, Prof. Dr. M. Jäger in Der Orthopäde (2016)

Article

Nonmyeloablative allogeneic stem cell transplantation for chronic lymphocytic leukaemia offers the possibility of disease control with minimal morbidity and mortality—a single institution experience

Allogeneic stem cell transplantation is a treatment option for patients with poor risk CLL. We conducted a retrospective analysis of all CLL patients allografted at our institution, the University Hospital of ...

G. Chakupurakal, S. Leitzke, P. Langerbeins, J. Schiller… in Annals of Hematology (2015)

Article

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

Despite major improvements in allogeneic hematopoietic cell transplantation over the past decades, corticosteroid-refractory (SR) acute (a) and chronic (c) graft-versus-host disease (GVHD) cause high mortality...

R Zeiser, A Burchert, C Lengerke, M Verbeek, K Maas-Bauer, S K Metzelder… in Leukemia (2015)

Article

Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma

We aimed at demonstrating non-inferiority of bortezomib/cyclophosphamide/dexamethasone (VCD) compared to bortezomib/doxorubicin/dexamethasone (PAd) induction therapy with respect to very good partial response ...

E K Mai, U Bertsch, J Dürig, C Kunz, M Haenel, I W Blau, M Munder, A Jauch… in Leukemia (2015)

Article

Meibography and meibomian gland measurements in ocular graft-versus-host disease

Meibomian gland loss in ocular GvHD was described as a mechanism contributing to dry eye and severe damage to the ocular surface. Infrared images of upper eyelid meibomian glands from 86 ocular GvHD patients, ...

L A Engel, S Wittig, F Bock, L Sauerbier, C Scheid… in Bone Marrow Transplantation (2015)

Article

Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV

Tyrosine kinase inhibitors (TKI) have changed the natural course of chronic myeloid leukemia (CML). With the advent of second-generation TKI safety and efficacy issues have gained interest. The randomized CML ...

L Kalmanti, S Saussele, M Lauseker, M C Müller, C T Dietz, L Heinrich… in Leukemia (2015)

Article

Optimization of health-care organization and perceived improvement of patient comfort by switching from intra-venous BU four-times-daily infusions to a once-daily administration scheme in adult hematopoietic stem cell recipients

Previous studies have shown an equivalent pharmacokinetic profile between four-times-daily (4QD) and once-daily (QD) administration of intra-venous (IV) BU, without increased toxicity. We assess the impact of ...

A Xhaard, P Rzepecki, D Valcarcel, S Santarone, S Fürst… in Bone Marrow Transplantation (2014)

Chapter and Conference Paper

A-Priori Convergence Analysis of a Discontinuous Galerkin Time-Domain Method to Solve Maxwell’s Equations on Hybrid Meshes

We study a multi-element Discontinuous Galerkin Time Domain (DGTD) method for solving the system of unsteady Maxwell equations. This method is formulated on a non-conforming and hybrid mesh combining a structu...

C. Durochat, C. Scheid in Numerical Mathematics and Advanced Applications 2011 (2013)

Article

Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA

We describe 20 patients with myeloma and 1 with primary amyloidosis from 15 centres, all with advanced renal failure, most of whom had PBSC mobilised using plerixafor following previous failed mobilisation by ...

K W Douglas, A N Parker, P J Hayden, A Rahemtulla, A D'Addio… in Bone Marrow Transplantation (2012)